These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37984556)

  • 21. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Biyun L; Yahui H; Yuanfang L; Xifeng G; Dao W
    Clin Microbiol Infect; 2024 May; 30(5):601-610. PubMed ID: 38280518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
    Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
    Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting.
    Busca A; Passera R; Maffini E; Festuccia M; Brunello L; Dellacasa CM; Aydin S; Frairia C; Manetta S; Butera S; Iovino G; Giaccone L; Sorror M; Storb R; De Rosa FG; Bruno B
    Bone Marrow Transplant; 2018 Oct; 53(10):1304-1310. PubMed ID: 29654289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogenic Hematopoietic Stem Cell Transplantation Is Feasible in Pediatric Patients with an Active or Recently Diagnosed Invasive Fungal Infection.
    Rotte LGY; Loeffen YGT; Bierings MB; Wolfs TFW; Lindemans CA
    Transplant Cell Ther; 2021 Sep; 27(9):781.e1-781.e5. PubMed ID: 34153502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.
    Little JS; Aleissa MM; Beluch K; Gonzalez-Bocco IH; Marty FM; Manne-Goehler J; Koo S; Hammond SP; Jacobson CA
    Blood Adv; 2022 Aug; 6(16):4821-4830. PubMed ID: 35802461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis.
    Oh SM; Byun JM; Chang E; Kang CK; Shin DY; Koh Y; Hong J; Kim TS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
    Sci Rep; 2021 Nov; 11(1):22160. PubMed ID: 34773060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
    Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
    J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and Determinants of Invasive Fungal Infections in Children With Solid and Hematologic Malignancies in a Nonallogeneic Stem Cell Transplantation Setting: A Narrative Review.
    Ruijters VJ; Oosterom N; Wolfs TFW; van den Heuvel-Eibrink MM; van Grotel M
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):345-354. PubMed ID: 30973485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients.
    Vázquez L; Salavert M; Gayoso J; Lizasoaín M; Ruiz Camps I; Di Benedetto N;
    Rev Esp Quimioter; 2017 Apr; 30(2):103-117. PubMed ID: 28198173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia.
    Wang ST; Chou CH; Chen TT; Lin CC; Bai LY; Yeh SP; Ho MW; Lien MY
    Front Cell Infect Microbiol; 2022; 12():1012334. PubMed ID: 36530436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes.
    Nganthavee V; Phutthasakda W; Atipas K; Tanpong S; Pungprasert T; Dhirachaikulpanich D; Krithin S; Tanglitanon S; Jutidamronphang W; Owattanapanich W; Chayakulkeeree M; Phikulsod P
    Support Care Cancer; 2019 Sep; 27(9):3613-3622. PubMed ID: 31165931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    Lien MY; Chou CH; Lin CC; Bai LY; Chiu CF; Yeh SP; Ho MW
    PLoS One; 2018; 13(6):e0197851. PubMed ID: 29883443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The D-index is not correlated with invasive fungal infection during the early-post engraftment phase among allogeneic hematopoietic stem cell transplant recipients.
    Abad CLR; Lahr B; O'Horo JC; Vijayvargiya P; Walker RC; Hogan WJ; Tande AJ
    Int J Hematol; 2020 Feb; 111(2):293-302. PubMed ID: 31709502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.
    Christen D; Sohlbach K; Metzelder SK; Wollmer E; Hoeffkes HG; Naumann R; Burchardt A; Rummel M; Trenker C; Dohse M; Mack E; Klameth A; Mann C; Kostrewa P; Brendel C; Wündisch T; Neubauer A; Wilhelm C; Burchert A
    Leuk Lymphoma; 2019 Aug; 60(8):2056-2061. PubMed ID: 30644334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections.
    Monzó-Gallo P; Chumbita M; Lopera C; Aiello TF; Peyrony O; Bodro M; Herrera S; Sempere A; Fernández-Pittol M; Cuesta G; Simó S; Benegas M; Fortuny C; Mensa J; Soriano A; Puerta-Alcalde P; Marco F; Garcia-Vidal C
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36861308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic SCT in patients with a history of invasive fungal infection.
    Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
    Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors for Invasive Fungal Infection in Children and Adolescents With Hematologic and Malignant Diseases: A 10-year Analysis in a Single Institute in Japan.
    Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
    Pediatr Infect Dis J; 2018 Dec; 37(12):1282-1285. PubMed ID: 30408007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.